Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction

被引:2
|
作者
Zhu, Xueting [1 ]
Yu, Yang [1 ]
Zhang, Jun [1 ]
Zhan, Yuxia [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构
[1] Soochow Univ, Clin Med Res Ctr, Affiliated Hosp 3, Changzhou, Peoples R China
关键词
2D-PCR; HLA-B*15:02; Genotyping; STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; HLA CLASS-I; CUTANEOUS ADVERSE-REACTIONS; DRUG-REACTIONS; RISK-FACTOR; CARBAMAZEPINE; ASSOCIATION; HAN; POPULATION;
D O I
10.1016/j.cca.2023.117654
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: HLA-B*15:02 is highly associated with carbamazepine-induced SJS/TEN; however, there is no rapid and accurate detecting method. Here, we present a method to distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles.Methods: The high-throughput two-dimensional polymerase chain reaction (2D-PCR) technology was employed to identify HLA-B*15:02 in two-tube reaction. And, 2D-PCR accuracy was verified by PCR-sequence based typing (PCR-SBT).Results: HLA-B*15:02 heterozygotes were identified by 14 melting valleys in the first tube reaction and none in the second, or by 13 melting valleys in the first tube reaction and one in the second. HLA-B*15:02 homozygote was identified by 13 melting valleys in the first tube reaction and none in the second. Three (0.16%) HLA-B*15:02 homozygotes and 84 (4.59%) HLA-B*15:02 heterozygotes were detected in 1830 samples of clinical general population without detecting 16 highly homologous alleles to HLA-B*15:02. The kappa test showed 100% coincidence between the 2D-PCR and PCR-SBT.Conclusions: 2D-PCR in two-tube reaction method for identifying HLA-B*15:02 was successfully established. Identification of HLA-B*15:02 is necessary prior to taking CBZ based on HLA-B*15:02 allele frequency.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry
    Dinh Van Nguyen
    Vidal, Christopher
    Hieu Chi Chu
    Nga Thi Quynh Do
    Tu Thi Linh Tran
    Huong Thi Minh Le
    Fulton, Richard B.
    Li, Jamma
    Fernando, Suran L.
    HUMAN IMMUNOLOGY, 2016, 77 (12) : 1140 - 1146
  • [32] Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
    Amstutz, Ursula
    Shear, Neil H.
    Rieder, Michael J.
    Hwang, Soomi
    Fung, Vincent
    Nakamura, Hidefumi
    Connolly, Mary B.
    Ito, Shinya
    Carleton, Bruce C.
    EPILEPSIA, 2014, 55 (04) : 496 - 506
  • [33] CD39+ regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers
    Shen, Meixin
    Lim, Joey Ming Er
    Chia, Cheryl
    Ren, Ee Chee
    IMMUNOBIOLOGY, 2020, 225 (01)
  • [34] Cost-effectiveness analysis of HLA-B*15:02 screening before treatment of epilepsy in Indonesia
    Tanoto, Eric
    Khosama, Herlyani
    Jehosua, Seilly
    Sekeon, Sekplin A. S.
    Karema, Winifred
    Mawuntu, Arthur H. P.
    Langi, Fima F. L. G.
    Seang, Lim Kheng
    EPILEPSY & BEHAVIOR, 2024, 155
  • [35] The association between HLA-B*15:02 and phenytoin-induced severe cutaneous adverse reactions: a meta-analysis
    Thanh Huong Phung
    Khanh Ngoc Cong Duong
    Gloria, Mac Ardy Junio
    Thien Khac Nguyen
    PHARMACOGENOMICS, 2021, 23 (01) : 49 - 59
  • [36] A new HLA-B*39 allele, B*39:168, closely related to B*39:05:01:02
    Planelles, Dolores
    Balas, Antonio
    Rodriguez-Cebria, Manuel
    Vicario, Jose L.
    HLA, 2021, 97 (01) : 75 - 76
  • [37] Two novel HLA class I alleles: HLA-A*02:1148 and HLA-B*44:386
    Loginova, Maria
    Makhova, Olga
    Paramonov, Igor
    HLA, 2024, 103 (04)
  • [38] A new HLA allele, HLA-B*08:108, described in two unrelated Spanish individuals
    Balas, A.
    Sanchez-Gordo, F.
    Gomez-Zumaquero, J. M.
    Prat, I.
    Vicario, J. L.
    TISSUE ANTIGENS, 2014, 83 (02): : 130 - +
  • [39] The new HLA-B*50:51 allele was generated by intralocus recombination between B*50:01:01:02 and B*14:02:01
    Sanchez-Gordo, F.
    Gomez-Zumaquero, J. M.
    Vicario, J. L.
    Balas, A.
    HLA, 2017, 90 (03) : 176 - +
  • [40] HLA-A*31:01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population
    Khor, Amy Hui-Ping
    Lim, Kheng-Seang
    Tan, Chong-Tin
    Kwan, Zhenli
    Tan, Wooi-Chiang
    Wu, David Bin-Chia
    Ng, Ching-Ching
    PHARMACOGENETICS AND GENOMICS, 2017, 27 (07): : 275 - 278